FDA Panel Recommends Approval Of HPV Test To Screen For Cervical Cancer
The panel unanimously voted that the benefits outweigh the risks of the test, called the cobas HPV Test, for women ages 25
fda panel recommends approval hpv test screen cervical cancer panel unanimously vote benefit outweigh risk test call cobas hpv test woman age